|
BUYINS.NET: LPHI, MBRK, MKTAY, NURO, NVEC, VEXP Have Also Been Added
To Naked Short List Today
|
 |
|
|
|
| Copyright: | M2 Communications Ltd. | | Source: | M2 PressWIRE | | Wordcount: | 2002 |
RDATE:05022008
BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list: Life Partners Holdings Inc (NASDAQ: LPHI), MiddleBrook Pharmaceuticals Inc. (NASDAQ: MBRK), Makita Corp. (NASDAQ: MKTAY), NeuroMetrix Inc. (NASDAQ: NURO), NVE Corp. (NASDAQ: NVEC), Velocity Express Corp. (NASDAQ: VEXP). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.
Life Partners Holdings Inc (NASDAQ: LPHI) through its subsidiary, Life Partners, Inc., operates as a financial services company that provides purchasing services for life settlements in the United States. It facilitates viatical and life settlement transactions by identifying, examining, and purchasing the policies as an agent. Life Partners Holdings' financial transactions involve the purchase of life insurance policies of terminally ill persons or elderly persons at a discount to their face value. The company was founded in 1971 and is based in Waco, Texas. With 11.96 million shares outstanding and 1.47 million shares declared short as of January 2008, there is a failure to deliver in shares of LPHI. According to quarterly data provided by the SEC, there were still 295,544 shares of LPHI that were failing-to-deliver as of September 28, 2007.
MiddleBrook Pharmaceuticals Inc. (NASDAQ: MBRK) engages in the development and commercialization of anti-infective drug products for the treatment of infectious diseases. It develops a proprietary, once-a-day pulsatile delivery technology called PULSYS. The company's pulsatile product candidates include Amoxicillin PULSYS for adults and adolescents with pharyngitis and/or tonsillitis; and Keflex PULSYS product candidate, based on the antibiotic cephalexin, which is in Phase I clinical trials for skin and skin structure infections. In addition, MiddleBrook Pharmaceuticals sells its Keflex products in both capsule and powder formulations for the treatment of skin and skin structure infections, and upper respiratory tract infections primarily through pharmaceutical distributors and wholesalers to physicians, hospitals, and pharmacies in the United States. It has a collaboration agreement with Par Pharmaceutical for the distribution and marketing of the company's generic formulation of Abbott's Biaxin XL (extended release clarithromycin). The company was founded in 1999. It was formerly known as Advancis Pharmaceutical Corporation and changed its name to MiddleBrook Pharmaceuticals, Inc. in June 2007. MiddleBrook Pharmaceuticals is headquartered in Germantown, Maryland. With 46.73 million shares outstanding and 155,800 shares declared short as of January 2008, there is a failure to deliver in shares of MBRK. According to quarterly data provided by the SEC, there were still 17,491 shares of MBRK that were failing-to-deliver as of September 28, 2007.
Makita Corp. (NASDAQ: MKTAY) engages in the manufacture and sale of a range of power tools for professional users worldwide. It offers drills, including pistol-grip drills, D-handle drills, spade-handle drills, and angle drills, as well as cordless drills cordless driver drills, which are used for drilling in metals, woods, and plastics; grinders comprising portable disc grinders and bench grinders; and sanders that include portable disc sanders and belt sanders; rotary hammers for construction industry; and ordinary hammers. The company also provides hammer drills that are used as conventional drills on metal and masonry in the civil engineering and electrical contracting industries; demolition hammers and electric breakers, which are used for shattering hard surfaces; cordless impact drivers; circular saws for carpenters in the homebuilding industry; slide compound saws; and cutters. In addition, it provides gardening household products consisting of chain saws, hand-held vacuum cleaners for home use, industrial vacuum cleaners, submersible pumps, and garden tools, such as hedge trimmers; engine-equipped grass cutters and lawn mowers for trimming tree fences and cutting grass; and various parts and accessories, such as saw blades, drill bits, and grinding wheels. It offers its products to commercial and professional users, such as those engaged in timber and metal processing, carpentry, and concrete and masonry works through distributors. The company, formerly known as Makita Electric Works, Ltd. was founded in 1915 and changed its name to Makita Corporation in 1991. Makita Corporation is headquartered in Anjo City, Japan. With 143.78 million shares outstanding and 20,400 shares declared short as of January 2008, there is a failure to deliver in shares of MKTAY.
NeuroMetrix Inc. (NASDAQ: NURO) designs, develops, and sells medical devices used to diagnose neuropathies and neurovascular disease in the United States. It offers NC-stat System, a point-of-service neurodiagnostic solution, which comprises disposable single use biosensors; NC-stat device and related components; and NC-stat docking station, an optional device that enables the physician to transmit data to its onCall information system. The company also offers DigiScope, which has an integrated digital fundus camera that allows for the capture of dilated retinal images in approximately ten minutes. In addition, it develops ADVANCE System, a diagnostic device that allows its customers to perform complex analyses of diagnostic data. The company markets its products through regional sales managers and independent sales agents to primary care and specialist physicians. NeuroMetrix has a strategic alliance with Cyberkinetics Neurotechnology Systems, Inc. The company was founded in 1996 and is headquartered in Waltham, Massachusetts. With 12.62 million shares outstanding and 3.4 million shares declared short as of January 2008, there is a failure to deliver in shares of NURO. According to quarterly data provided by the SEC, there were still 74,582 shares of NURO that were failing-to-deliver as of September 28, 2007.
NVE Corp. (NASDAQ: NVEC) engages in the development and sale of devices using spintronics, a nanotechnology, which utilizes electron spin rather than electron charge to acquire, store, and transmit information. The company provides standard sensors that detect the presence of a magnet or metal to determine position or speed; custom sensors primarily for medical devices; and couplers that use semiconductor input stages, primarily for factory and industrial networks. NVE Corporation also licenses the spintronic magnetoresistive random access memory technology, commonly known as MRAM. It sells its products through distributors primarily in the United States, Europe, and Asia. The company was founded in 1982 and is headquartered in Eden Prairie, Minnesota. With 4.64 million shares outstanding and 471,800 shares declared short as of January 2008, there is a failure to deliver in shares of NVEC. According to quarterly data provided by the SEC, there were still 13,402 shares of NVEC that were failing-to-deliver as of September 28, 2007.
Velocity Express Corp. (NASDAQ: VEXP) together with its subsidiaries, provides logistics solutions to consumers and businesses in the United States and Canada. It offers distribution logistics services, which include the receipt of customer bulk shipments that are divided and sorted at metropolitan locations and delivered to multiple locations; scheduled logistics services comprising daily pickup and delivery of parcels; and expedited logistics services, including expedited point-to-point service for customers with time sensitive delivery requirements. The company primarily serves customers operating in the healthcare, commercial and office products, financial, transportation and logistics, technology, and energy sectors. Velocity Express Corporation was founded in 1979 and is headquartered in Westport, Connecticut. With 2.83 million shares outstanding and 117,700 shares declared short as of January 2008, there is a failure to deliver in shares of VEXP. According to quarterly data provided by the SEC, there were still 12,601 shares of VEXP that were failing-to-deliver as of September 10, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 1,800,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. LPHI has previously paid a $10,945.00 data fee to BUYINS.NET. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, Buyins.net
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net
((M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com)).
This is a news service of Thomson Business Intelligence Service ©2006. This content is for your personal use only, subject to Terms and Conditions. No redistribution allowed.
|
|
|
|
|
